Over the past couple of years, pharmacies have been gravitating toward a core model that provides healthcare services as well as traditional retail offerings. This was recently exhibited by Walgreens Boots Alliance 's move to invest $1 billion over four years in building out co-located pharmacy-clinics. Prior to that, we saw CVS Health (NYSE: CVS) acquire Aetna , which had long been known for its medical healthcare management through its insurance services.
With the announcement of its Aetna acquisition, CVS moved closer to its goal of becoming a (self-proclaimed) "premier health innovation company." Now, as the company continues to expand, one competitor is basically handing it a pile of patients and prescriptions. But can this turn into a boost for CVS's bottom line?
Image source: Getty Images.
For further details see:
What Will an Unexpected Revenue Boost Mean for This Leading Pharmacy Stock's Bottom Line?